Trials / Not Yet Recruiting
Not Yet RecruitingNCT07198373
Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Beijing GoBroad Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single-center, Phase IV clinical trial designed to collect and analyze data on the efficacy and safety of zanubrutinib as maintenance therapy following CAR-T cell therapy in subjects with non-Hodgkin B-cell lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Maintenance Therapy Group | Patients achieving remission (complete or partial) at the 3-month post-CAR-T infusion assessment receive oral zanubrutinib capsules for maintenance therapy for 2 years. |
Timeline
- Start date
- 2025-09-20
- Primary completion
- 2027-12-30
- Completion
- 2028-12-30
- First posted
- 2025-09-30
- Last updated
- 2025-09-30
Source: ClinicalTrials.gov record NCT07198373. Inclusion in this directory is not an endorsement.